Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 136 Head and Neck Neoplasms 96 Squamous Cell Carcinoma of Head and Neck 89 Carcinoma, Non-Small-Cell Lung 58 Colonic Neoplasms 44 Rectal Neoplasms 38 Neoplasm Metastasis 34 Neoplasms 28 Pancreatic Neoplasms 24 Lung Neoplasms 18 Carcinoma, Squamous Cell 18 Stomach Neoplasms 15 Tongue Neoplasms 13 Esophageal Neoplasms 13 Salivary Gland Neoplasms 11 Recurrence 10 Breast Neoplasms 10 Laryngeal Neoplasms 9 Mouth Neoplasms 8 Esophageal Squamous Cell Carcinoma 8 Carcinoma 8 Adenocarcinoma Of Esophagus 8 Adenocarcinoma of Lung 7 Neoplasms, Squamous Cell 6 Hypopharyngeal Neoplasms 6 Carcinoma, Renal Cell 6 Parkinson Disease 4, Autosomal Dominant Lewy Body 5 Oropharyngeal Neoplasms 5 Nasopharyngeal Carcinoma 5 Carcinoma, Hepatocellular 5

Interventions

binimetinib 2 ipatasertib 1 exemestane 1 encorafenib 1 baricitinib 1 atezolizumab 1 Vemurafenib 1 VP-102 1 Trabectedin 1 Spironolactone 1 Paclitaxel 1 Low-Level Light Therapy 1 Leuprolide 1 Fluorouracil 1 Everolimus 1 Equipment and Supplies 1 Dacarbazine 1 Cetuximab 1 Cantharidin 1 BF-200 ALA 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Skin Diseases × Cetuximab × Clear all

NCT00240682 2012-02-22

CTXSCC

Centre Hospitalier of Chartres

Phase 2 Completed

Carcinoma, Squamous Cell, Skin Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡